INFORMATIVE       

Consorta, a leading healthcare group purchasing and resource management company, has awarded a new contract to Clinical Innovations, effective October 1. The three-year agreement provides value to existing and new users of CI's unique "KOALA" Intrauterine Pressure Catheters (IUPCs), and "KIWI," its Vacuum Assisted Delivery line.

Wm. Dean Wallace, CEO of Clinical Innovations, commented, "Many health care providers have recognized that quality and unique technology can make the difference in mother and baby's health. The Consorta contract shows that new technology, focused on safety and outcomes, not just price, makes the most sense for the healthcare industry and that this is important to Consorta members."

"We are pleased to offer our members the opportunity to purchase the high quality products offered by Clinical Innovations. The new agreement will broaden the portfolio of savings opportunities for our membership," commented Mike Murphy, Manager, Med/Surg Contracts at Consorta.

About Clinical Innovations

Founded in 1993 by Wm. Dean Wallace, MD, PhD, Clinical Innovations has been a leader in developing products focused on infant and mother safety during the delivery process. Their market share has grown consistently, fueling the ability to develop new products--where innovation makes the difference. For more information about Clinical Innovations go to www.clinicalinnovations.com or contact Paul Huish, Director of Marketing and Sales, 801-268-8200, 747 West 4170 South, Murray, UT 84123.

About Consorta
Consorta, Inc., based in suburban Chicago, is a leading healthcare resource management and group purchasing organization, whose shareholders are faith based or non profit health systems. As a cooperative Consorta's shareholders and participants share fully in the organization's bottom-line performance, as well as receiving significant discounts through scale purchasing economies.

Consorta's Shareholders are among the leading integrators of non-profit health care in America, sponsoring significant care providers in many parts of the country. Consorta's Shareholder health care systems operate more than half of all Catholic hospitals in the United States, own many extended and alternate care sites and have extensive affiliate relationships with other non-profit hospitals and alternate care facilities. The Consorta membership encompasses nearly 500 acute care facilities, representing 55,944 beds, and more than 2000 non-acute care sites. For more information about Consorta, Inc. go to www.consorta.com.

The agreement was facilitated through HealthCare Links, an outsourced National Accounts group www.healthcarelinks.com.